Acta Scientific Ophthalmology (ISSN: 2582-3191)

Short Communication Volume 4 Issue 11

Tackling an Age-Related Macular Degeneration in the Low and Middle Income Countries

Raba Thapa*

Associate Professor of Ophthalmology (NAMS), Vitreo-Retina Specialist, Tilganga Institute of Ophthalmology, Kathmandu, Nepal

*Corresponding Author: Raba Thapa, Associate Professor of Ophthalmology (NAMS), Vitreo-Retina Specialist, Tilganga Institute of Ophthalmology, Kathmandu, Nepal.

Received: August 27, 2021 ; Published: October 07, 2021.

×

Age related macular degeneration (AMD) is one of the public eye health problem that accounts for the 8.7% of the total blindness in the world [1]. AMD has been the most common cause of blindness among elderly in developed countries [2,3]. Life expectancy has been markedly improved in low and middle income countries like in higher income countries due to facilities in health care services and improved nutrition. With the ageing population, AMD has been the emerging cause of visual impairment and blindness among elderly in the low and middle income countries [4-7]. Population based studies reported AMD as the most common cause of morbidity among the elderly and leading cause of blindness after cataract [5].

×

References

  1. Resnikoff S., et al. “Global data on visual impairment in the year 2002”. Bulletin of the World Health Organization 11 (2004): 844-851.
  2. Mitchell P., et al. “Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study”. Ophthalmology 10 (1995): 1450-1460.
  3. Klein R., et al. “Prevalence of age-related maculopathy. The Beaver Dam Eye Study”. Ophthalmology 99 (1992): 933-943.
  4. Woo JH., et al. “The epidemiology of age-related macular degeneration in the Indian Subcontinent”. Acta Ophthalmology 3 (2009): 262-269.
  5. Thapa SS., et al. “Prevalence and pattern of Vitreo-retinal disorders in Nepal: the Bhaktapur glaucoma study”. BMC Ophthalmology 13 (2013): 9.
  6. Thapa R., et al. “Prevalence of risk factors for age related macular degeneration in Nepal: The Bhaktapur Retina Study”. Clinical Ophthalmology 11 (2017): 963-972.
  7. Gupta SK., et al. “Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE Feasibility Study”. Investigative Ophthalmology and Visual Science3 (2007): 1007-1011.
  8. Krishnaiah S., et al. “Risk factors for age-related macular degeneration: findings from the Andhra Pradesh Eye Disease Study in South India”. Investigative Ophthalmology and Visual Science12 (2005): 4442-4449.
  9. Age-related Eye Disease Study Research Group. “Risk factors associated with age-related macular degeneration: a case-control study in the Age-related Eye Disease Study: Age-related Eye Disease Study Report Number 3”. Ophthalmology12 (2000): 2224-2232.
  10. Thapa R., et al. “Age-related macular degeneration in Nepal”. Kathmandu University Medical Journal3 (2011): 165-169.
  11. Bird AC., et al. “An international classification and grading system for age-related maculopathy age-related macular degeneration. The International ARM Epidemiological Study Group”. Survey of Ophthalmology5 (1995): 367-374.
  12. Thapa R., et al. “Population awareness of diabetic eye disease and age related macular degeneration in Nepal: the Bhaktapur Retina Study”. BMC Ophthalmology 15 (2015): 188.
×

Citation

Citation: Raba Thapa. “Tackling an Age-Related Macular Degeneration in the Low and Middle Income Countries".Acta Scientific Ophthalmology 4.11 (2021): 25-26.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US